Gene · 4824
Papers3,429
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,429
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular decoupling of lineage identity and morphology in aggressive variant prostate cancer. | medRxiv | 2026 | 41542660 | PubTator, text mining | PubMed |
| Global Evaluation of Congenital Heart Disease-Associated Non-Coding Variants. | Res Sq | 2026 | 41542063 | PubTator, text mining | PubMed |
| Day surgery mode of multi-modal image AI fusion targeted transperineal biopsy technique using electromagnetic navigation tracking system under local anesthesia. | BMC Urol | 2026 | 41540385 | PubTator, text mining | PubMed |
| Unlocking the power of extracellular vesicles: multi-omics integration for cancer biomarker discovery. | Biomark Res | 2026 | 41527006 | PubTator, text mining | PubMed |
| Protocol for generating human vascular organoids via orthogonal activation of ETV2 and NKX3.1. | STAR Protoc | 2026 | 41447524 | PubTator, text mining | PubMed |
| Utility of HoxB13 in differential diagnosis of female genital tract lesions with putative prostatic differentiation. | Virchows Arch | 2026 | 41335140 | PubTator, text mining | PubMed |
| Semi-synthetic sapogenin derivatives inhibit inflammation-induced tumorigenic signaling alterations in prostate carcinogenesis. | Steroids | 2026 | 41290083 | PubTator, text mining | PubMed |
| Elinzanetant: First Approval. | Drugs | 2026 | 41222830 | PubTator, text mining | PubMed |
| Spectrum of Histopathologic Findings in Transgender Men Undergoing Gender-Affirming Gynecologic Surgery Following Preoperative Androgen Therapy: A Tertiary Care Center Study. | Int J Surg Pathol | 2026 | 40856051 | PubTator, text mining | PubMed |
| Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate Cancer. | Eur Urol | 2026 | 40774853 | PubTator, text mining | PubMed |
| NKX3.1 Expression in Male Breast Carcinoma: The Phantom Menace. | Int J Surg Pathol | 2026 | 40620066 | PubTator, text mining | PubMed |
| Utilization of NKX3.1 and P501S to distinguish primary breast carcinoma from metastatic prostatic adenocarcinoma in male patients. | Virchows Arch | 2026 | 40347269 | PubTator, text mining | PubMed |
| Diagnostic Utility of NKX3.1 in Mesenchymal Chondrosarcoma on Needle Biopsy: A Case Report of a Supraclavicular Soft Tissue Mass with Literature Review. | Turk Patoloji Derg | 2026 | 40323235 | PubTator, text mining | PubMed |
| Adherent Natural Killer Cells De Novo Express IL-2Rα and Sustain Long-Lasting, Potent Anti-Tumor Activity in Picomolar Concentrations of IL-2. | J Cancer Immunol (Wilmington) | 2025 | 41907300 | PubTator, text mining | PubMed |
| A Hierarchy of Luminal Transcription Factors Defines AR Cistrome and Is Lost in Neuroendocrine Prostate Cancer. | Cancer Heterog Plast | 2025 | 41768226 | PubTator, text mining | PubMed |
| Therapeutic targeting of Aurora Kinase A in advanced prostate cancer. | Serican J Med | 2025 | 41658018 | PubTator, text mining | PubMed |
| Bladder Washing Cytology in the Detection of High-Grade Prostatic Adenocarcinoma: A Case Report. | Cureus | 2025 | 41487799 | PubTator, text mining | PubMed |
| Diagnostic Algorithm for Secondary Extramammary Paget Disease from Institutional Cases and Literature Review. | Cancers (Basel) | 2025 | 41463263 | PubTator, text mining | PubMed |
| The Protean Nature of 14-3‑3 Proteins in G Protein-Coupled Receptor Signaling: Emphasizing Selectivity and Dynamic Interactions at the Neurokinin Receptor 3 Interface. | ACS Pharmacol Transl Sci | 2025 | 41409172 | PubTator, text mining | PubMed |
| Could GSTP1, PTEN and NKX3.1 gene expression be novel markers in the relationship between prostate cancer and epigenetics? | BMC Cancer | 2025 | 41299324 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4824/papers?page=4